Angiotensin II and the pathophysiology of cardiovascular remodeling (Q34239817)

31 July 2017

1 reference

title

Angiotensin II and the pathophysiology of cardiovascular remodeling (English)

1 reference

ORCID Public Data File 2021

31 July 2017

1 reference

1 reference

1 reference

author name string

Williams B

series ordinal

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

American Journal of Cardiology

31 July 2017

published in

1 reference

31 July 2017

volume

87

1 reference

31 July 2017

issue

8A

1 reference

31 July 2017

page(s)

10C-17C

1 reference

Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Opposing actions of angiotensin II on microvascular growth and arterial blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

A potential role for angiotensin II-induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Antagonism of the renin-angiotensin-aldosterone system and collagen metabolism in cardiac fibroblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

The angiotensin II type 2 receptor: an enigma with multiple variations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Reactivity of small blood vessels in hypertension: relation with structural changes. State of the art lecture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Pulsed Doppler: diameter, blood flow velocity and volumic flow of the brachial artery in sustained essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Mechanical influences on vascular smooth muscle cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Angiotensin II stimulates MAP kinase kinase kinase activity in vascular smooth muscle cells, Role of Raf

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Relationship between small-artery structure and systolic, diastolic and pulse pressure in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Effects of endothelin-1 and vasopressin on resistance arteries of spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Mechanics and composition of human subcutaneous resistance arteries in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Arterial stiffness in hypertensive subjects with or without end-stage renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Regulation of the structural remodelling of the myocardium: from hypertrophy to heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Serum Carboxy-Terminal Propeptide of Procollagen Type I Is a Marker of Myocardial Fibrosis in Hypertensive Heart Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Role of tissue angiotensin II in myocardial remodelling induced by mechanical stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Effects of losartan on hypertension and left ventricular mass: a long-term study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Angiotensin II and extracellular matrix homeostasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Hypertension detection and follow-up program. Summary of the baseline characteristics of the hypertensive participants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

End-stage renal disease in African-American and white men. 16-year MRFIT findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

TGF-beta1 DNA polymorphisms, protein levels, and blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Transforming growth factor-beta 1 hyperexpression in African American end-stage renal disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Altered expression of transforming growth factor-beta S in chronic renal rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Early induction of transforming growth factor-beta via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Tyrosine kinase dependent expression of TGF-beta induced by stretch in mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

Mechanical strain-induced extracellular matrix production by human vascular smooth muscle cells: role of TGF-beta(1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901507-7

10.1016/S0002-9149(01)01507-7

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference